Professional Documents
Culture Documents
October 2007
This Guide is based on the requirements for labelling of scheduled drugs and poisons
which became effective on 1 September 2007. These requirements are constantly
under review and future modifications are to be anticipated.
! CONTENTS "
INTRODUCTION
III
INTERPRETATION
IV
LABELLING
General
Legibility
1
1
Elements of a Label
Signal Words
Cautionary Statements
Declaration of the Contents
Directions for Use
Safety Directions
Warning Statements
First Aid
Manufacturer or Distributor
Modified Labelling
Transport Containers and Wrappings
Dispensary, Industrial, Laboratory and Manufacturing Chemicals
Dispensed Medicines
Immediate Wrappers
Selected Containers and Measure Packs
Ampoules, Prefilled Syringes and Injection Vials
Gas Cylinders
Paints and Tinters
Camphor and Naphthalene
Essential Oils
3
3
4
5
6
6
6
7
7
7
7
7
8
8
8
8
9
9
10
10
Schedule 2 Requirements
11
Schedule 3 Requirements
13
Schedule 4 Requirements
15
Schedule 5 Requirements
17
Schedule 6 Requirements
20
Schedule 7 Requirements
22
Schedule 8 Requirements
25
28
Reference Books
30
INTRODUCTION
The Standard for the Uniform Scheduling of Drugs and Poisons (SUSDP) contains certain legal
requirements for the labelling of poisons and drugs that are for sale to the public. The labelling system
it contains was initially designed to harmonise the requirements of Australia and New Zealand and was
phased in over a five year period which commenced on 1 July 1995 and ended on 30 June 2000. In
July 2004 the Required Advisory Statements for Medicine Labels (RASML) document was established
by the Therapeutic Goods Administration to enable the transfer of all mandatory label advisory
statements from the SUSDP and the Therapeutic Goods Regulations to a new document, separate from
but linked to TGO 69 - General requirements for labels for medicines (the Labelling Order)
[http://www.tga.gov.au/docs/html/tgo/tgo69.htm]. The Labelling Order makes it mandatory for
medicine labels to include any label advisory statements specified in Required Advisory Statements for
Medicine Labels. The RASML provided a one-year transition period for existing products and took
full effect on 1 July 2005. As a consequence the majority of SUSDP medicines advisory labelling
requirements were replaced with references to the RASML, effective May 2006.
This Guide has been prepared to assist manufacturers and packers of poisons to draft labels which
comply with the SUSDP requirements as they exist on 1 January 2007. The information it contains is
not complete nor is it intended to be the sole source of reference. It is essential for users of this Guide
to also refer to the SUSDP and Commonwealth, State or Territory legislation which relate to the
packaging and labelling of drugs, poisons, therapeutic goods, agricultural chemicals and veterinary
chemicals. To assist the reader to refer back to the SUSDP, references to relevant paragraphs and subparagraphs have been included in this Guide.
A separate Guide to the Packaging, Labelling and Regulation of Paints, Tinters and Related Products
is also available.
The following publications also should be used for guidance, where appropriate, when designing labels
for therapeutic goods, agricultural products, veterinary products, paints or dangerous goods:
#
Therapeutic Goods Order No. 69 - General requirements for labels for medicines;
Therapeutic Goods Order No. 69A - Amendment to Therapeutic Goods Order No. 69 General requirements for labels for medicines;
Therapeutic Goods Order No. 37 General Requirements for labels for Therapeutic Devices;
Labelling Code of Practice: Designing usable non-prescription medicine labels for consumers;
Veterinary Labelling Code: The Code of Practice for Labelling Veterinary Chemical Products;
Ag Labelling Code;
FAISD Handbook: Handbook of First Aid Instructions, Safety Directions and Warning
Statements for Agricultural and Veterinary Chemicals;
Australian Dangerous Goods Code (ADG) (Australian Code for the transport of dangerous
goods by road and rail);
NDPSC Guide to the Packaging, Labelling and Regulation of Paints, Tinters and Related
Products. [www.tga.gov.au/ndpsc/paintgui.htm]
A listing of all publications quoted in this Guide, and where they can be obtained from, is included in
the Reference Books section at the end of this document
As poisons labelling is the responsibility of the States and Territories, when further information or
assistance is required reference should be made to these contacts, not to the National Drugs and
Poisons Schedule Committee (NDPSC). A list of State and Territory contacts is included at the end of
this Guide.
ii
Schedule 8
Schedule 4
Schedule 7
Schedule 3
Schedule 2
Schedule 6
Schedule 5
iii
INTERPRETATION
[Taken from SUSDP Part 1.]
(b)
the Australian Approved Name for the poison, not including synonyms, as listed
in the publication entitled Therapeutic Goods Administration Approved
Terminology for Medicines, July 1999, or its successor, published by the
Therapeutic Goods Administration, Canberra; or, if the poison is not listed in that
publication,
(ii)
the international non-proprietary name recommended for the poison by the World
Health Organisation; or, if no such name is recommended,
(iii)
the English name, not including synonyms, by which the poison is described in
the British Pharmacopoeia, the British Pharmaceutical Codex, the Australian
Pharmaceutical Formulary and Handbook or the British Pharmacopoeia
(Veterinary); or, if the poison is not described in any of those publications,
(iv)
the approved name given to the poison by the Medicines Commission of Great
Britain; or, if no such name is given,
(v)
the accepted scientific name or the name descriptive of the true nature and origin
of the poison;
(ii)
the English name given to the poison by the International Organisation for
Standardisation; or, if no such name is given,
(iii)
the English name given to the poison by the British Standards Institution; or, if no
such name is given,
(iv)
the Australian Approved Name for the poison, not including synonyms, as listed
in the publication entitled Therapeutic Goods Administration Approved
Terminology for Drugs, January 1993 (ISBN 0 644 28628 8),,or its successor,
iv
the English name, not including synonyms, by which the poison is described in
the British Pharmacopoeia, the British Pharmaceutical Codex, the Australian
Pharmaceutical Formulary and Handbook or the British Pharmacopoeia
(Veterinary); or, if the poison is not described in any of those publications,
(vi)
the approved name given to the poison by the Medicines Commission of Great
Britain; or, if no such name is given,
(vii)
the international non-proprietary name recommended for the poison by the World
Health Organisation; or, if no such name is recommended,
(viii) the accepted scientific name or the name descriptive of the true nature and origin
of the poison.
Blood means whole blood extracted from human donors.
Blood components means therapeutic components that have been manufactured from blood
(including red cells, white cells, stem cells, platelets and plasma), except for products
derived through fractionation of plasma.
'Child-resistant closure' means:
(a)
(b)
(c)
a closure that complies with the requirements for a child-resistant closure in the
Australian Standard AS1928-2001 entitled Child-resistant packages as specified or
amended from time to time;
a closure approved by any order made under section 10(3) of the Commonwealth
Therapeutic Goods Act 1989; or
in the case of a can fitted with a press on lid, a lid of the design known as 'double tight'
or 'triple tight'.
complies with the requirements of the Australian Standard AS1928-2007 entitled Childresistant packages as specified or amended from time to time;
(b)
is reclosable and complies with the requirements of at least one of the following
standards as specified or amended from time to time.
(c)
(i)
(ii)
the British Standards Institution Standard BS EN 28317:1993 entitled Childresistant packaging - Requirements and testing procedures for reclosable
packages;
(iii)
(iv)
the United States Code of Federal Regulations, Title 16, Section 1700.15, entitled
Poison prevention packaging standards and Section 1700.20, entitled Testing
procedure for special packaging;
(d)
is in the form of blister or strip packaging in which a unit of use is individually protected
until the time of release and that complies with Section 3 (Requirements for nonreclosable packages) of Australian Standard AS 1928-2001 Child-resistant packages.
Compounded in relation to a substance means combined with one or more other therapeutically
active substances in such a way that it cannot be separated from them by simple
dissolution or other simple physical means.
Debitterised neem seed oil means highly purified oil from the neem seed containing only fatty acids
and glycerides of fatty acids.
Dermal use means application to the skin primarily for localised effect.
'Designated solvent' means the following:
acetone
dimethylformamide
N-(N-dodecyl)-2-pyrrolidone
hydrocarbons, liquid
styrene
tetrachloroethylene
1,1,1-trichloroethane.
(b)
External in relation to the use of a poison means application in the ears, eyes or nose or to a body
surface other than in the mouth, rectum, vagina, urethra or other body orifice.
First Schedule Paint means a paint containing the specified proportion of any substance in the First
Schedule to Appendix I of this Standard.
Graphic material means the material which is to be deposited on another material by a graphic
instrument during writing, drawing or marking and includes cores of pencils, school
pastels or crayons, blackboard chalks, finger or showcard colours, poster paints and
watercolour blocks.
'Height' in relation to letters used for words, expressions or statements on labels means the height of
capital letters or lower case letters having an ascender or a descender.
Hemp seed oil means the oil obtained by cold expression from the ripened fruits (seeds) of Cannabis
sativa.
vi
'Immediate container' includes all forms of containers in which a poison is directly packed but does
not include any such container intended for consumption or any immediate wrapper.
'Immediate wrapper' means metal foil, plastic foil, waxed paper or any other such material not
intended for consumption when used as the first wrapper for a dosage unit or dressing.
'Internal use' means administration:
(a)
(b)
(ii)
that label or portion of the label on which the name of the product is most prominently
shown and which is primarily designed to attract attention; or
(b)
where the name of the product is equally prominent on two or more labels or portions of
a label, each of those labels or portions of the label on which the name of the product is
equally prominent.
vii
(a)
(b)
(b)
limits the delivery of the contents to drops each of which is not more than 200
microlitres.
'SUSDP' means the Standard for the Uniform Scheduling of Drugs and Poisons.
Second Schedule Paint means a paint containing the specified proportion of any substance in the
Second Schedule to Appendix I of this Standard.
Selected container means:
(a)
(b)
(c)
any other container for substances for therapeutic use having a nominal capacity of ten
millilitres or less.
(b)
(c)
Third Schedule Paint means a paint containing the specified proportion of any substance in the
Third Schedule to Appendix I of this Standard.
'Tinter' means any pigment or admixture of pigment with other substances, in powder, semi-solid or
liquid form, sold or supplied for the purpose of adding to paint in order to change the colour of
the paint.
Topical use means application of a poison for the purpose of producing a localised effect on the
surface of the organ or within the tissue to which it is applied.
viii
ix
LABELLING
[Adapted from SUSDP Part 2]
General
A label is written, printed or graphic matter on or attached to a container to identify its contents and
inform the consumer about its qualities, uses and hazards.
Labels must be written in characters that are durable and be printed on or securely attached to the
outside of the immediate container and, where the immediate container is enclosed in a primary pack,
on the primary pack also. They must not obscure any ribs, embossing or printed words required to be
on a poison container.
As well as the name of the product and its manufacturer, a products label also may be required, by
legislation, to contain one or more of the following elements:
IMPORTANT It is an offence to sell or supply a poison or dangerous good that is not labelled in
accordance with the requirements of State and Territory legislation.
It is the responsibility of the manufacturer, packer or distributor of a poison to ensure that a product is
correctly and adequately labelled.
The following information is provided to assist label designers to comply with the labelling
requirements of the SUSDP which has been made mandatory by adoption into State and Territory
poisons legislation.
When designing a label, the prime concerns should be that it is clear, concise and comprehensible so
that the consumer understands the information that appears on it and that it also complies with the
appropriate labelling regulations.
Legibility
(Paragraphs 3 and 18)
Letter height
All printing, unless otherwise specified, must be 1.5 mm or more in height measured on capital letters
or lower case letters with ascenders or descenders, for example b, d, g, p. Smaller print may be used if
approval has been given by an appropriate authority. Approval will not be given for the use of letters
less than 1mm.
Language
Labels must be written in English and must not include any statement, expression, device, trade name
or description that:
is false or misleading in relation to the safety of the poison or any of its ingredients;
Elements of a Label
Signal Words
[SUSDP sub-paragraphs 7(1)(a)]
The SUSDP requires specific signal words to be placed at the top of the main (front) label of drugs and
poisons. These signal words indicate either the restriction applying to the drug or poison or the relative
danger of the product. The colour of the signal words and the background are no longer specified, but
a distinct contrast with the background is necessary so that these words stand out and are legible even
under poor lighting conditions. The signal words applicable to each schedule are as follows:
Schedule
Signal Words
PHARMACY MEDICINE
CAUTION
POISON
DANGEROUS POISON
CONTROLLED DRUG
the first line of the main (front) label. Signal words may be spread over two lines on labels for
small containers;
not less than half the height of the largest letter or numeral on the label or 1.5 mm
whichever is the larger, however they do not have to be larger than 6 mm on containers
having a capacity of 2 litres or less or 15 mm on containers of more than 2 litres;
The only things permitted to be on the same line of the main label as the signal words are the
Australian Dangerous Goods Code Class labels (e.g. the red diamond 'FLAMMABLE LIQUID' symbol);
and for Schedule 5 poisons, a brief statement about the hazard of the poison which may be placed
alongside the signal word 'CAUTION' (e.g. 'CAUTION' - May irritate eyes). Class labels and hazard
statements are not a mandatory requirement of the SUSDP, but the use of a hazard statement is
encouraged as a means of informing the user of specific problems associated with a product.
Cautionary Statements
[Paragraph 7(1)(b) to (j)]
Unless otherwise specified under the individual statement below, each cautionary statement must:
start on a separate line of the label, but long statements may be spread over two or more
lines if necessary;
be printed in letters four-tenths the height of the letters of the signal words.
The only things permitted to be on the same lines as the cautionary statements are the Australian
Dangerous Goods Code Class labels (e.g. the red diamond 'FLAMMABLE LIQUID' symbol). These Class
labels are not a mandatory requirement of the SUSDP, but may be used if the manufacturer so desires.
This cautionary statement is required on the labels of all Schedule 8 drugs. It is to be placed on the line
immediately below the signal words 'CONTROLLED DRUG' and nothing else can be on the same line.
This cautionary statement is required on all poison labels and is to be on the line immediately below
the signal words or, in the case of a Schedule 8 drug, immediately below the cautionary statement
'POSSESSION WITHOUT AUTHORITY ILLEGAL'.
This cautionary statement is required on all dry chlorinating compounds which have more than 10%
available chlorine. The statement is required to be on the line immediately below the cautionary
statement 'KEEP OUT OF REACH OF CHILDREN'.
This cautionary statement is required on dish washing machine products which contain alkaline salts
(Schedule 5). It must be placed on the line immediately below the cautionary statement 'KEEP OUT OF
REACH OF CHILDREN'.
These cautionary statements are required on the labels of all aqueous solutions containing paraquat
(Schedule 7). Each statement must be on a separate line and the group of statements must be
immediately below the cautionary statement 'KEEP OUT OF REACH OF CHILDREN'.
This cautionary statement is required on the labels of all poisons when safety directions are included on
the label. This may be abbreviated to 'READ SAFETY DIRECTIONS' if there is insufficient room on the
label for the full phrase. It is to be placed either immediately below the cautionary statement 'KEEP
OUT OF REACH OF CHILDREN' or below any other statements that are required to be immediately below
the cautionary statement'KEEP OUT OF REACH OF CHILDREN'.
FLAMMABLE
[Sub-paragraph 7(1)(h)]
Any liquid poison classified as a flammable liquid under the Australian Dangerous Goods Code must
be labelled with the cautionary statement 'FLAMMABLE' in bold-face sanserif capital letters unless it is
already labelled in accordance with that Code.
Any preparation which is intended to be used for the treatment of animals must be labelled with the
cautionary statement 'FOR ANIMAL TREATMENT ONLY'. Apart from being on the main (front) label, the
exact position is not specified.
DO NOT SWALLOW
[Sub-paragraph 7(1)(j)]
This cautionary statement is required on Schedule 5 poisons intended for any purpose other than
internal or pesticidal use. It is to be placed on the main label or as part of the directions for use.
Preparations classified as poisons must be labelled with the approved name and quantity, proportion or
strength of each poison they contain. This declaration must be printed in bold-face sanserif capital
letters.
When labelling therapeutic goods, agricultural products or veterinary products refer to the guides
provided by the relevant registration authorities for this purpose noting that all 'active constituents'
must be declared.
Variations of Approved names
'ALKALINE SALTS', ALIPHATIC AMINES, AROMATIC AMINES, LIQUID EPOXY RESINS,
'LIQUID HYDROCARBONS' and 'QUATERNARY AMMONIUM COMPOUNDS' are considered to be approved
names for poisons included in these Schedule 5 class entries.
Where a product contains a mixture of Schedule 5 solvents (designated solvents), which individually
are below the exemption limit of 25% but collectively exceed that specification, 'LIQUID
HYDROCARBONS', 'KETONES', 'SOLVENTS' or 'OTHER SOLVENTS' may be used as approved names for
respective components of the mixture when declaring their content. (See the definition for 'designated
solvent' in SUSDP Part 1.)
If the product is a pesticide or an animal treatment which contains organophosphorus compounds or
carbamates, the declaration of contents must be followed by the statement 'AN ANTICHOLINESTERASE
COMPOUND'. This statement is not required if the poison is dazomet, mancozeb, metiram, propineb,
thiram, tri-allate, ziram or zineb or if the product is a pressurised spray pack for household use.
Strength or Proportion
[paragraph 8]
for human therapeutic use, in the manner prescribed in Therapeutic Goods Order No. 69
General requirements for labels for medicines; or
for other preparations, as the mass or volume of the poison per stated mass or volume of the
preparation as appropriate.
Directions for use must be included on the label for any poison prepared for a specific purpose, except
for a preparation classified as a Schedule 4 or a Schedule 8 poison. Directions for use should be clear
and easy to understand.
Safety Directions
[Sub-paragraph 7(1)(n) and Appendix F]
Safety directions are required on the label of any poison that may be harmful to the user. If a poison is
listed in Appendix F of the SUSDP, the safety directions must include the statements specified for the
poison in that Appendix unless:
the poison is an agricultural or veterinary chemicals (including pesticides) registered by the
Australian Pesticides and Veterinary Medicines Authority, as the safety directions for these
poisons are contained in the FAISD Handbook or will be provided during the registration
process; or
a medicine for human use when compliant with the requirements of the Required Advisory
Statements for Medicine Labels.
The manufacturer or distributor is encouraged to include any additional statements that may be
necessary to ensure that the poison is used safely. It is the responsibility of the manufacturer, packer,
and supplier of a drug or poison to ensure that the purchaser or user of a product is given sufficient
information to be able to use it correctly and safely.
When a preparation contains more than one poison, the safety directions included on the label should
be an appropriate combination of the statements required for each of the poisons.
Safety directions must be grouped together as a distinct section of the label and be preceded by the
words 'SAFETY DIRECTIONS' printed in bold-face sanserif capital letters.
Warning Statements
[Sub-paragraph 7(1)(o) & Appendix F]
If a poison is listed in Appendix F of the SUSDP, the label must include any warning statements
specified for the poison in that Appendix unless:
the poison is an agricultural or veterinary chemicals (including pesticides) registered by the
Australian Pesticides and Veterinary Medicines Authority, as the safety directions for these
poisons are contained in the FAISD Handbook or will be provided during the registration
process; or
a medicine for human use when compliant with the requirements of the Required Advisory
Statements for Medicine Labels.
The manufacturer or distributor may include additional warning statements as deemed necessary to
ensure that the user is adequately warned of any hazard associated with the poison.
Warning statements must be grouped together as a distinct section of the label and placed:
immediately after the words 'SAFETY DIRECTIONS' if safety directions are included on the
label; or
immediately before the directions for use if there are no safety directions.
First Aid
[Sub-paragraph 7(1)(p) and Appendix E]
Poisons must be labelled with appropriate directions for first aid attention in case of poisoning. It is
the responsibility of the manufacturer, packer and supplier of a drug or poison to ensure that the first
aid directions included on the label of a poison are appropriate for a specific product. These directions
must be preceded by the words 'FIRST AID' printed in bold-face capital letters.
A poison classified as a Schedule 3, 4, or 8 poison, or when packed and labelled for human internal
use, is not required to be labelled with first aid directions.
If a product consists of a primary pack in which two or more smaller containers of poisons need
different first aid directions, the primary pack can be labelled 'FIRST AID: See inner packs', but each of
the inner containers must have the first aid instructions appropriate for its contents.
Appendix E of the SUSDP is a guide for the development of suitable first aid instructions. First aid
instructions for agricultural and veterinary chemicals are not included in the SUSDP, but may be found
in the FAISD Handbook or will be provided during the registration process.
If a preparation consists of a mixture of poisons, the first aid instructions should be adjusted to be
appropriate for the admixture. Any such modification should be concise and readily understood.
Manufacturer or Distributor
[Sub-paragraph 7(1)(q)]
The name and address in Australia of the manufacturer or distributor must be on the label. A post
office box or overseas address is not acceptable.
Modified Labelling
[Paragraphs 6 & 9 to 17]
Modified labelling requirements apply for transport containers, poisons packed and sold for
dispensary, industrial, laboratory and manufacturing use, immediate wrappers, small containers (10 mL
or less), gas cylinders, paint, tinter for paint, camphor and naphthalene. The requirements are:
There are no requirements in the SUSDP for the labelling of transparent covers or wrappers, hampers,
packing cases, crates or any other containers used solely for transport or delivery.
Poisons that are only for dispensary, industrial, laboratory and manufacturing use may be labelled in
accordance with the Australian Safety and Compensation Councils National Code of Practice for the
Labelling of Workplace Substances [NOHSC:2012(1994)] instead of the SUSDP if so desired.
Dispensed Medicines
[Paragraph 14 & 45]
Medicines that have been dispensed on and in accordance with a prescription, supplied by a medical,
dental or veterinary practitioner as part of their respective professional practices, or prepared by a
pharmacist for an individual patient, do not have to be labelled in accordance with the SUSDP
requirements. However, individual State or Territory regulations may apply to dispensed medicines.
If a dispensed medicine is listed in Part 3, paragraph 45 of the SUSDP, then the label must include any
warning statements required (referenced to specific Appendix F warning statements).
Immediate Wrappers
[Paragraph 6]
Examples of immediate wrappers are single dose powder papers, the waxed paper used for wrapping
individual lozenges and the sealed paper envelope which holds a single finger dressing. Poisons in
immediate wrappers must be enclosed in a properly labelled primary pack.
The immediate wrapper must be conspicuously labelled with:
the name of the manufacturer or distributor or the brand or trade name of the poison.
When packed in a fully labelled primary pack, the labelling requirements for immediate containers that
are measure packs or containers (having a nominal capacity of 10 mL or less) are reduced to
the approved name and the quantity, proportion or strength of the poison;
the name of the manufacturer or distributor or the specific brand or trade name of the
product; and
the cautionary statement 'FOR ANIMAL TREATMENT ONLY if for the treatment of animals only'.
Ampoules or injection vials or pre-filled syringes when packed in fully labelled primary packs are only
required to be labelled with:
the approved name and the quantity, proportion or strength of the poison;
the name of the manufacturer or distributor or the specific brand or trade name of the
product; and
the cautionary statement 'FOR ANIMAL TREATMENT ONLY if for the treatment of animals only'.
Plastic ampoules joined with a strip of plastic and which are opened as they are detached from the strip
are only required to be labelled with the approved name or the trade name of the product and the
quantity, proportion or strength of the poison provided that the strip to which they are attached is
labelled as above and they are contained in a properly labelled primary pack.
Gas Cylinders
[Paragraph 15]
Where the label is affixed to the shoulder of a gas cylinder, the requirements for nothing to be written
on the same line of the main label as the signal words or any cautionary statements are waived.
For a more extensive guide to the labelling of paints and related products refer to the NDPSC Guide to
the Packaging, Labelling and Regulation of Paints, Tinters and Related Products.
A paint that contains only Schedule 5 poisons does not have to be labelled as a poison.
If a paint contains the proportion (or less) of any of the poisons listed below, it is also exempt from
poison labelling requirements:
5 % antimony as the element or any of its compounds other than titanate pigments;
5 % barium as its salts other than sulfate or metaborate;
0.1 % cadmium as the element or its compounds;
5 % chromium as ammonium, barium, potassium, sodium, strontium or zinc chromate;
0.1 % of selenium as the element or its compounds;
10 % by volume ethylene glycol mono alkyl ethers and their acetates;
5 % by weight methylene chloride (dichloromethane);
50 % by volume toluene;
50 % by volume xylene;
0.1 % lead as the element or its compounds (0.2 % as an impurity in zinc based paint);
If a paint contains one or more of these poisons above the proportion shown, the main (front) label
must have:
the signal word 'WARNING' printed in bold-face sanserif capital letters not less than 5
mm in height on the first line with nothing else on that line;
the cautionary statement 'KEEP OUT OF REACH OF CHILDREN' printed in bold-face
sanserif capital letters not less than 2.5 mm in height on the second line; and
the name and proportion of the poison.
If the paint contains more than the above proportion of antimony, barium, cadmium, chromium or,
selenium the following warning statements must be on the label immediately below the cautionary
statement 'KEEP OUT OF REACH OF CHILDREN':
This paint is dangerous to health, even when dry.
For industrial use only.
Do not use on toys or furniture.
Do not use on, in or around the home.
If the paint contains more than the above proportion of ethylene glycol monoalkyl ethers or their
acetates, methylene chloride, toluene or xylene the following warning statements must be on the label
immediately below the cautionary statement 'KEEP OUT OF REACH OF CHILDREN':
Breathing the vapour is dangerous.
Provide adequate ventilation during application.
Do not use in the presence of a naked flame.
Do not smoke.
If the paint contains more than the above proportion of lead the following warning statements must be
on the label immediately below the cautionary statement 'KEEP OUT OF REACH OF CHILDREN':
This paint contains lead and is dangerous to health, even when dry.
For industrial use only.
10
Devices that contain only camphor or naphthalene in block, ball, disc or pellet form for domestic use
and which prevent removal or ingestion of their contents during normal use, if packed in a fully
labelled primary pack, are only required to have the signal word 'poison' and the approved name of the
poison embossed or indelibly written on them.
Essential Oils
[See schedule entries for specific oils]
Essential oils classified as poisons are listed in either Schedule 5 or Schedule 6 of the SUSDP.
Some of these oils are exempt from the full packaging and labelling requirements of the SUSDP,
subject to restricted packaging and specific warning statements.
11
Schedule 2 Requirements
Label contents
Legal requirements
PHARMACY MEDICINE
No specifications.
NETT CONTENTS
SAFETY DIRECTIONS
12
WARNING STATEMENTS
PHARMACY MEDICINE
KEEP OUT OF REACH OF CHILDREN
PRODUCT NAME
Ingredients g/L, mL/L, g/Kg or mL/Kg
Directions for use
Quantity
Name and address
For external or topical use & regulated by the TGA
PHARMACY MEDICINE
KEEP OUT OF REACH OF CHILDREN
PRODUCT NAME
Ingredients g/L, mL/L, g/Kg or mL/Kg
Directions for use
FIRST AID:
Quantity
Name and address
13
Schedule 3 Requirements
Label contents
Legal requirements
No specifications.
NETT CONTENTS
SAFETY DIRECTIONS
14
WARNING STATEMENTS
PRODUCT NAME
Ingredients g/L, mL/L, g/Kg or mL/Kg
Directions for use
Quantity
Name and address
15
Schedule 4 Requirements
Label contents
Legal requirements
No specifications.
NETT CONTENTS
SAFETY DIRECTIONS
WARNING STATEMENTS
16
(v)
PRODUCT NAME
Each tablet contains:(name of poison) mg
Quantity
Name and address
PRODUCT NAME
Each tablet contains:(name of poison) mg
Quantity
Name and address
17
Schedule 5 Requirements
Label contents
Legal requirements
CAUTION
FLAMMABLE
DO NOT SWALLOW
No specifications.
AN ANTICHOLINESTERASE COMPOUND
18
NETT CONTENTS
SAFETY DIRECTIONS
WARNING STATEMENTS
PRODUCT NAME
Contains: (NAME OF POISON) g/L, mL/L, g/kg, mL/kg
Directions for use
SAFETY DIRECTIONS:
FIRST AID:
Quantity
Name and address
19
CAUTION
KEEP OUT OF REACH OF CHILDREN
BURNS SKIN AND THROAT
DO NOT SWALLOW
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
PRODUCT NAME
Contains: ALKALINE SALTS
g/kg, g/L
Directions for use
SAFETY DIRECTIONS: Strongly alkaline. Avoid contact
with eyes and skin
FIRST AID: For advice, contact a Poisons
Information Centre (Phone eg Australia 131 126;
New Zealand 0800 764 766 ) or a doctor .
If swallowed , do NOT induce vomiting.
If in eyes, hold eyelids apart and flush the eye
continuously with running water. Continue flushing
until advised to stop by the Poisons Information Centre
or a doctor, or for at least 15 minutes.
If skin or hair contact occurs, remove contaminated
clothing and flush skin and hair with running water.
Continue flushing with water until advised to stop by
the Poisons Information Centre or a doctor.
Quantity
Name and address
20
Schedule 6 Requirements
Label contents
Legal requirements
POISON
FLAMMABLE
No specifications.
AN ANTICHOLINESTERASE COMPOUND
NETT CONTENTS
SAFETY DIRECTIONS
21
WARNING STATEMENTS
General
POISON
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
PRODUCT NAME
Contains: (NAME OF POISON) g/L, mL/L, g/kg, mL/kg
Directions for use
SAFETY DIRECTIONS:
FIRST AID:
Quantity
Name and address
22
Schedule 7 Requirements
Label contents
Legal requirements
DANGEROUS POISON
No specifications.
AN ANTICHOLINESTERASE COMPOUND
NETT CONTENTS
23
WARNING STATEMENTS
General requirements
DANGEROUS POISON
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
PRODUCT NAME
Contains: (NAME OF POISON) g/L, mL/L, g/kg, mL/kg
Directions for use
SAFETY DIRECTIONS:
FIRST AID:
Quantity
Name and address
24
DANGEROUS POISON
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
PRODUCT NAME
Active Constituent: HYDROFLUORIC ACID
Directions for use
g/L
SAFETY DIRECTIONS: Avoid contact with eyes. Wear eye protection when mixing or using. Avoid contact with skin. Wear
protective gloves when mixing or using. Avoid breathing vapour or spray mist. Obtain a supply of calcium gluconate gel. Wash
gloves thoroughly immediately after use
Highly corrosive. Contact with eyes even for short periods can cause blindness. Causes severe burns, which are not likely to be
immediately painful or visible.
FIRST AID: For advice, contact a Poisons Information Centre (Phone eg Australia 131 126; New Zealand 0800 764 766) or a
doctor (at once). If swallowed, do NOT induce vomiting. If in eyes, hold eyelids apart and flush the eye continuously with
running water. Continue flushing until advised to stop by the Poisons Information Centre or a doctor, or for at least 15 minutes.
If skin contact occurs, immediately remove contaminated clothing. Flush skin under running water for 15 minutes. Then apply
calcium gluconate gel. Contact the Poisons Information Centre.
Quantity
Name and address
25
Schedule 8 Requirements
Label contents
Legal requirements
CONTROLLED DRUG
No specifications.
NETT CONTENTS
SAFETY DIRECTIONS
26
(viii)
27
CONTROLLED DRUG
POSSESSION WITHOUT AUTHORITY ILLEGAL
KEEP OUT OF REACH OF CHILDREN
PRODUCT NAME
Contains: (NAME OF POISON) g/L, mL/L, g/kg, mL/kg
Quantity
Name and address
28
Pharmaceutical Services
ACT Health,
Locked Bag 5
WESTON ACT 2611
Telephone
(02) 6205 1700
Fax
(02) 6205 0997
Website: http://www.health.act.gov.au/c/health?a=da&did=10054021&pid=1074232898
NORTHERN TERRITORY
Poisons Control
Department of Health & Community Services, Northern Territory
PO Box 40596
CASUARINA NT 0811
Telephone: 08 8922 7341
Fax: 08 8922 7200
Website:
http://www.nt.gov.au/health/healthdev/environ_health/application_forms/poisons_control.shtml
QUEENSLAND
SOUTH AUSTRALIA
29
TASMANIA
VICTORIA
WESTERN AUSTRALIA
30
Reference Books
.
Guide to Labelling Drugs and Poisons in accordance with the Standard for the Uniform
Scheduling of Drugs and Poisons
Therapeutic Goods Order No. 69 - General requirements for labels for medicines
Therapeutic Goods Order No. 69A - Amendment to Therapeutic Goods Order No. 69 - General
requirements for labels for medicines
Therapeutic Goods Order No. 37 General Requirements for labels for Therapeutic Devices
Labelling Code of Practice: Designing usable non-prescription medicine labels for consumers
Australian Dangerous Goods Code (ADG) (Australian Code for the transport of dangerous
goods by road and rail)
Veterinary Labelling Code: The Code of Practice for Labelling Veterinary Chemical Products
Ag Labelling Code
FAISD Handbook: Handbook of First Aid Instructions, Safety Directions and Warning
Statements for Agricultural and Veterinary Chemicals;
ASCC website:
http://www.ascc.gov.au/ascc/AboutUs/Publications/NationalStandards/IndexofNationalSt
andardsCodesofPracticeandrelatedGuidanceNotes.htm
NDPSC Guide to the Packaging, Labelling and Regulation of Paints, Tinters and Related
Products
Australian Standard AS 1580.301.1-1992 : Paints and related materials - Methods of test - Nonvolatile content by mass
[This standard has been updated - AS 1580.301.1-2005/Amdt 1-2006]